THC (Delta-9-THC)
Delta-9-Tetrahydrocannabinol · THC · Discovered 1964
Learn about THC (Delta-9-Tetrahydrocannabinol), the primary psychoactive cannabinoid in cannabis. Explore its mechanism of action, therapeutic benefits, side effects, legal status, and latest research.
Psychoactive
Yes
Discovered
1964
Effects
9 documented
Benefits
5 studied
Overview
Delta-9-Tetrahydrocannabinol (THC) is the most abundant and well-known psychoactive compound in the cannabis plant, first isolated and synthesized by Israeli chemist Raphael Mechoulam and Yechiel Gaoni in 1964. THC is responsible for the characteristic euphoric high associated with cannabis consumption and is the primary driver of both recreational and many medical applications of the plant. It is produced in the trichomes of female cannabis flowers as THCA (tetrahydrocannabinolic acid), which converts to active THC through decarboxylation — a process triggered by heat during smoking, vaporizing, or cooking.
THC interacts with the human endocannabinoid system (ECS), a complex cell-signaling network that plays a role in regulating mood, appetite, pain sensation, immune function, and memory. The discovery of THC led directly to the identification of the endocannabinoid system in the early 1990s, fundamentally changing our understanding of human neurobiology. Modern cannabis cultivars have been selectively bred to produce THC concentrations ranging from 15% to over 30%, compared to historical averages of 3-5% in the 1970s and 1980s.
THC has demonstrated significant therapeutic potential across numerous clinical trials and observational studies. The FDA has approved synthetic THC formulations including dronabinol (Marinol) and nabilone (Cesamet) for chemotherapy-induced nausea and AIDS-related wasting syndrome. Research continues to explore THC's applications in chronic pain management, multiple sclerosis spasticity, PTSD, insomnia, and appetite stimulation in cancer patients.
Mechanism of Action
THC exerts its effects primarily by binding to CB1 receptors in the central nervous system and CB2 receptors in the peripheral immune system. CB1 receptors are concentrated in brain regions responsible for memory (hippocampus), coordination (cerebellum and basal ganglia), pleasure and reward (ventral tegmental area and nucleus accumbens), and pain perception (periaqueductal gray). When THC binds to CB1 receptors, it mimics the endogenous cannabinoid anandamide, inhibiting the release of neurotransmitters such as GABA and glutamate. This modulation of neurotransmitter release produces the characteristic effects of euphoria, altered sensory perception, relaxation, and appetite stimulation. THC also activates CB2 receptors on immune cells, contributing to anti-inflammatory effects. Additionally, THC interacts with non-cannabinoid receptors including TRPV1 vanilloid receptors (involved in pain perception), GPR55 receptors, and serotonin 5-HT3A receptors, contributing to its complex pharmacological profile.
Therapeutic Effects
Potential Benefits
Chronic Pain
Strong evidence from multiple randomized controlled trials. A 2015 systematic review in JAMA found that cannabinoids, primarily THC, were associated with significant reduction in chronic pain across 28 RCTs.
Chemotherapy-Induced Nausea
FDA-approved indication. Synthetic THC (dronabinol/nabilone) is prescribed for nausea and vomiting unresponsive to conventional anti-emetics. Multiple clinical trials demonstrate superiority over placebo.
Multiple Sclerosis Spasticity
Moderate evidence. Nabiximols (Sativex), a 1:1 THC:CBD oromucosal spray, is approved in over 25 countries for MS spasticity. Clinical trials show significant improvement in patient-reported spasticity scores.
PTSD
Emerging evidence. Observational studies and small clinical trials suggest THC may reduce nightmares, hyperarousal, and flashbacks in PTSD patients by modulating fear memory extinction through the endocannabinoid system.
Appetite Loss / Wasting Syndrome
FDA-approved indication. Dronabinol is approved for AIDS-related anorexia. THC stimulates appetite through CB1 receptor activation in the hypothalamus, increasing ghrelin release and enhancing food palatability.
Side Effects & Risks
- ⚠Short-term memory impairment during intoxication
- ⚠Anxiety and paranoia at high doses or in sensitive individuals
- ⚠Dry mouth (xerostomia) and dry eyes
- ⚠Increased heart rate (tachycardia) for 2-3 hours post-consumption
- ⚠Impaired motor coordination and reaction time
- ⚠Dizziness and lightheadedness
- ⚠Potential for psychological dependence with chronic heavy use
- ⚠Risk of cannabis hyperemesis syndrome with long-term heavy use
Concentration & Sources
Typical Concentration
15-30% in modern cannabis flower; 60-90% in concentrates; 5-100mg per dose in edibles
Found In
All cannabis cultivars, with highest concentrations in unfertilized female flowers (sinsemilla). Dominant in virtually all recreational and most medical cannabis strains. Also available as synthetic formulations (dronabinol, nabilone).
Legal Status
Federally illegal in the United States (Schedule I). Legal for medical use in 38 states and recreational use in 24 states as of 2025. Legal in Canada, Uruguay, and parts of Europe for medical or recreational use.
Research Summary
THC is the most extensively researched cannabinoid, with thousands of peer-reviewed studies spanning over six decades. The National Academies of Sciences, Engineering, and Medicine published a comprehensive review in 2017 concluding there is conclusive or substantial evidence that cannabis (primarily THC) is effective for chronic pain in adults, chemotherapy-induced nausea, and multiple sclerosis spasticity. Research into THC's neuroprotective properties has shown promise in preclinical models of Alzheimer's disease, with THC demonstrating the ability to reduce amyloid beta plaque accumulation. Large-scale epidemiological studies continue to refine our understanding of THC's long-term safety profile, particularly regarding cardiovascular effects, mental health outcomes, and adolescent brain development. The ongoing shift toward cannabis legalization is accelerating clinical research, with numerous Phase II and III trials currently underway for conditions including chronic pain, PTSD, insomnia, and opioid use disorder.
Related Cannabinoids
THC (Delta-9-THC) FAQ
How long does THC stay in your system?
THC can be detected in urine for 3-30 days depending on frequency of use, with daily users potentially testing positive for up to 90 days. In blood, THC is detectable for 1-2 days for occasional users and up to 7 days for chronic users. Hair tests can detect THC metabolites for up to 90 days. The primary metabolite tested for is THC-COOH, which is fat-soluble and accumulates in adipose tissue, leading to prolonged detection windows in frequent users.
What is the difference between THC and CBD?
THC and CBD are both cannabinoids found in cannabis but have fundamentally different effects. THC is psychoactive and produces the euphoric high associated with cannabis by binding directly to CB1 receptors in the brain. CBD is non-psychoactive and does not produce a high; it modulates the endocannabinoid system indirectly and can actually counteract some of THC's effects, such as anxiety. THC is effective for pain, nausea, appetite stimulation, and sleep, while CBD is used for anxiety, seizures, inflammation, and general wellness.
Is THC legal?
THC's legal status varies by jurisdiction. In the United States, THC remains federally classified as a Schedule I controlled substance. However, 38 states have legalized medical cannabis containing THC, and 24 states plus Washington D.C. have legalized recreational cannabis as of 2025. Canada fully legalized cannabis in 2018. In Europe, medical cannabis containing THC is legal in Germany, Italy, the Netherlands, and several other countries. Always verify your local and state laws before purchasing or possessing THC products.
What is the recommended THC dosage for beginners?
For cannabis beginners, the recommended starting dose is 2.5-5mg of THC, particularly for edibles where effects are delayed and longer-lasting. For inhalation methods like smoking or vaporizing, one small puff followed by a 15-minute wait is advisable. The principle of 'start low and go slow' is widely endorsed by medical professionals. Individual tolerance varies significantly based on genetics, body weight, prior exposure, and the specific product's cannabinoid and terpene profile.
Can you overdose on THC?
A fatal overdose from THC alone has never been documented in medical literature. The lethal dose of THC in humans is estimated to be extraordinarily high — roughly 1,500 pounds of cannabis consumed within 15 minutes, which is physically impossible. However, consuming too much THC can cause intensely unpleasant effects including severe anxiety, paranoia, nausea, vomiting, rapid heart rate, and temporary psychotic symptoms. These effects, while distressing, are self-limiting and typically resolve within a few hours.
Continue Exploring
Disclaimer: Cannabinoid information is provided for educational purposes only. Medical benefits are based on published research and are not intended as medical advice. Individual responses to cannabinoids vary. Always consult a healthcare professional before using cannabis for medical purposes. Legal status information is current as of publication but may change — verify your local laws.